#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

z UL

Thinking About Idiopathic Pulmonary Fibrosis?

16. 4. 2020 Source: Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is one of the most prognostically severe and difficult-to-treat lung diseases. It affects about 5 million people worldwide, with an estimated incidence in the Czech Republic of 1/100,000 inhabitants. Although it is a relatively rare disease, due to its high mortality rate (the median survival of untreated patients is 2−3 years), it is essential to have a basic awareness of the possible symptoms of IPF. Expert sources even state that, according to statistics, only pancreatic cancer leads to a faster death…

Muž se chytá za srdce

American Heart Association: Side Effects of Statins Overview and Context

The American Heart Association (AHA) report provides an updated summary of knowledge on the safety of statin use. Despite warnings appearing in professional literature and general media, it assures…
15. 4. 2020 Source: Cardiovascular Risks
histologie_genetika_onkologie

Third Generation Targeted Therapy for ROS1-Positive NSCLC

The potent third-generation tyrosine kinase inhibitor, lorlatinib, has shown activity in preclinical studies against nearly all known mutations in the ALK and ROS1 genes that lead to resistance to…
15. 4. 2020 Source: Genetic Profile and Treatment of NSCLC
rentgen_plic_snimek

Key Role of HRCT in Diagnosing Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is often an unjustly overlooked disease. The truth is that it is a rare disease, but the prognosis for patients is very poor. To improve quality of life and chances of…
15. 4. 2020 Source: Pulmonary Fibrosis
Výběr inkontinenční pomůcky dle absorpce

The Choice of Incontinence Aids Matters −⁠ But How Not to Get Lost Among Them?

Despite significant advances in medicine, a large number of patients still struggle with incontinence, which limits their comfort and reduces their quality of life. If treatment options have been…
14. 4. 2020 Source: Incontinence
PL_glukometr_diabetes

Prevalence of Diabetics Among Patients with COVID-19 and the Impact of DM on the Course of Infection

Italian authors published the results of a meta-analysis of studies at the end of March, assessing the prevalence of diabetes among individuals infected with SARS-CoV2 and the impact of diabetes on…
14. 4. 2020 Source: Modern Treatment of Diabetes
Idiopatická plicní fibróza

Idiopathic Pulmonary Fibrosis: Rare Disease with Severe Prognosis

Idiopathic pulmonary fibrosis (IPF) represents a diagnostic and therapeutic challenge. This rare diffuse primary fibroproliferative involvement of lung tissue is characterized by progressive…
14. 4. 2020 Source: Pulmonary Fibrosis

Impact of Empagliflozin on the Risk of Cardiovascular Death and Need for Hospitalization Due to Heart Failure

In the EMPA-REG OUTCOME study, empagliflozin reduced the risk of cardiovascular death and the number of hospitalizations due to heart failure in patients with type 2 diabetes (T2DM) who had confirmed...
10. 4. 2020 Source: Diabetes
PL_duchodkyne_seniorka_pece

Domestic application of biological asthma treatment improves quality of life and reduces doctor visits

The benefits of the possibility of home application of omalizumab, a monoclonal antibody indicated for patients with severe allergic asthma, are summarized by Dr. Jakub Novosad, Ph.D., from the…
9. 4. 2020 Source: Asthma under control
Osteoartróza kolene

Comparison of Efficacy and Safety of Unsaponifiable Soy and Avocado Oil and Chondroitin Sulfate in the Treatment of Knee Osteoarthritis

Osteoarthritis is the most common joint disease in adult patients, with its prevalence increasing with age, and these issues most frequently affect the knee joint. In the treatment of knee…
8. 4. 2020 Source: Osteoarthritis Therapy

The Presence of COPD Worsens the Course of COVID-19 –⁠ Results of Epidemiological Studies

Among the at-risk populations during the current COVID-19 pandemic are older individuals and those suffering from chronic comorbidities. The presence of chronic obstructive pulmonary disease (COPD),…
8. 4. 2020 Source: Treatment of Asthma and COPD
tromboembolismus_vte_ct_vysledky

Are All Patients Really Suitable for Thromboprophylaxis Treated This Way?

A study published this year aimed to assess how often the risk of VTE is assessed in routine clinical practice in internally ill patients, what proportion of patients are suitable for…
8. 4. 2020 Source: Thromboprophylaxis
medicína_konzultace_lékař_pacient_prohlídka_karta

Forgotten Pulmonologists: COVID-19 Detection in Patients with Lung Disease

The Czech Pneumological and Phthisiological Society of ČLS JEP (ČPFS) submitted a request to the Ministry of Health of the Czech Republic on March 25, 2020, to allow pulmonologists to send patients…
7. 4. 2020 Source: Asthma under control

Direct Comparison of Ixekizumab and Adalimumab in Patients with Psoriatic Arthritis

The final results of the direct comparison of ixekizumab and adalimumab in the therapy of biologic-naïve patients with psoriatic arthritis were presented at the annual conference of the American…
6. 4. 2020 Source: Biological Treatment
JIP_pacient_nemocnice

Quality of Nutrition in ICU and Subsequent Quality of Life Are Closely Related

In the past decade, there has been a reduction in mortality associated with severe sepsis or acute respiratory failure. However, the number of people requiring care in rehabilitation facilities,…
6. 4. 2020 Source: Enteral Nutrition
1 105 106 107 108 109 115
Filter by speciality
Remove filters

Popular this week
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#